<DOC>
	<DOCNO>NCT01102699</DOCNO>
	<brief_summary>Diabetes mellitus associate significant reduction circulate progenitor cell ( CPCs ) . These include endothelial progenitor cell ( EPCs ) , involve cardiovascular homeostasis repair . A reduction CPCs metabolic patient associate increased risk future adverse cardiovascular outcome . Therefore , way active stimulate increase CPC level diabetes actively pursue . Experimental animal study preliminary data human indicate bone marrow defect causally relate low CPC level diabetes . Our previous data rat indicate diabetes reduces bone marrow responsiveness granulocyte colony-stimulating factor ( G-CSF ) term progenitor cell mobilization . In present study , aim investigate bone marrow responsiveness pharmacological mobilization CPC diabetic patient compare non-diabetic subject .</brief_summary>
	<brief_title>Bone Marrow Progenitor Cell Mobilization Diabetes</brief_title>
	<detailed_description>Diabetes mellitus associate significant reduction circulate progenitor cell ( CPCs ) . CPCs define surface expression stem cell antigen CD34 CD133 . These cell include endothelial progenitor cell ( EPCs ) , involve cardiovascular homeostasis repair . EPCs characterize co-expression endothelial antigen ( ) , KDR . A reduction CPCs metabolic patient associate increased risk future adverse cardiovascular outcome , myocardial infarction , stroke , revascularization , etc . Therefore , way active stimulate increase CPC level diabetes actively pursue . Indeed , several drug stimulate CPCs EPCs , fully clear active also diabetic patient . The mechanisms account CPC reduction diabetes include defective bone marrow mobilization , reduce survival increase home outside bloodstream . Experimental animal study preliminary data human indicate bone marrow defect causally relate low CPC level diabetes . Our previous data rat indicate diabetes reduces bone marrow responsiveness G-CSF term c-kit+/Sca-1+ progenitor cell mobilization . There also experimental evidence type 2 diabetic rat specific form autonomic neuropathy impairs bone marrow mobilization progenitor cell . In present study , aim investigate bone marrow responsiveness pharmacological mobilization CPC diabetic patient compare non-diabetic subject . Diabetic subject control subject administer single dose granulocyte colony stimulate factor ( G-CSF ) progenitor cell quantify 24 hour G-CSF administration . Progenitor cell analyze flow cytometry basis expression CD34 , CD133 KDR . Mean percentage variation CPCs EPCs compare diabetic versus non diabetic patient understand whether diabetes associate significant defective mobilization progenitor cell . As secondary aim , diabetic patient divide without diabetic autonomic neuropathy ( DAN ) understand DAN modulate bone marrow responsiveness G-CSF .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Diabetes mellitus ( case ) absence diabetes ( control ) ; Age 2565 ; Both sex ; Capability provide informed consent . Age &lt; 25 &gt; 65 ; Fertile woman ; Recent ( within 2 month ) acute illness ; Chronic immune infectious disease ; Current remote hematological disorder ; Leukocytosis , leukopenia thrombocytopenia ; Organ transplantation immune suppression ; Altered liver function ; Severe renal failure ( eGFR &lt; 30 mL/min/m2 ) ; Anomalies lymphocytes subpopulation ; High basal level CD34+ cell count ; Allergy Filgrastim ; Bronchial asthma chronic lung disorder ; Current remote cancer ; Deny impossibility provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>stem cell</keyword>
	<keyword>bone marrow</keyword>
	<keyword>mobilization</keyword>
</DOC>